CHICAGO, Dec. 24, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Oracle Corp. (Nasdaq: cronym>ORCL), Eloqua Inc. (Nasdaq: cronym>ELOQ), Automatic Data Processing Inc. (Nasdaq: cronym>ADP), Salesforce.com Inc. (NYSE: cronym>CRM) and IBM (NYSE: cronym>IBM).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Friday's Analyst Blog:
Oracle Expands Cloud, Buys Eloqua
Oracle Corp. (Nasdaq: cronym>ORCL) is aggressively building its position in the cloud-computing arena through strategic acquisitions. After acquiring cloud-based service providers RightNow Technologies in January and Taleo Corp in April this year, Oracle recently announced the acquisition of Eloqua Inc. (Nasdaq: cronym>ELOQ) for approximately $871.0 million.
Virginia-based Eloqua develops cloud-based automated marketing solutions. Eloqua software helps businesses monitor marketing and sales initiatives. Its tools are also used by marketing departments to analyze online behavior and buying preferences in order to find prospective customers.
According to Reuters, Eloqua has a strong customer base, which comprises Automatic Data Processing Inc. (Nasdaq: cronym>ADP), AON Plc, Dow Jones, Polycom Inc. and National Instruments Corp. The company also has an online sales partnership with Salesforce.com Inc. (NYSE: cronym>CRM), one of the major competitors of Oracle in the automated marketing software market. Eloqua earned revenue of $23.8 million in the recently concluded third quarter of 2012.
In August 2012, Eloqua completed its initial public offering ("IPO") that generated net proceeds of approximately $87.7 million. Oracle's offer price of $23.50 per share is double that of Eloqua's IPO price of $11.50 per share and represents a 31% premium to its December 19 closing price of $17.92. Following the announcement, Eloqua share price surged 32.0% to close at $23.66 on December 20, 2012.
According to data from Bloomberg, Oracle's offer price equates to more than 9 times Eloqua's trailing 12 months sales, a premium compared to 6.3 times for RightNow and 7.1 times for Taleo. As Oracle is comparatively a late entrant in the cloud-computing market, we believe that the company is paying a premium to boost its product portfolio in order to catch up with Salesforce and IBM (NYSE: cronym>IBM).
According to market research firm Gartner, marketing is one of the four fastest growing areas of enterprise sales applications on the SaaS (software-as-a-service) platform. Gartner projects a robust increase in marketing spending due to improving e-commerce sales, higher adoption of social networks, rapid usage of mobile devices and improving marketing effectiveness.
We believe that higher spending on marketing bodes well for Oracle, as strong demand for Eloqua's revenue performance management application will boost its top-line. Oracle intends to integrate Eloqua into its Oracle Marketing Cloud and it will be an important addition to Oracle's customer experience portfolio.
We expect Oracle to continue pursuing strategic acquisitions of technology start-ups that can be easily synchronized with its product lines. These acquisitions will help Oracle to expand its customer base over the long term. The strategic acquisitions will also help Oracle to reduce competition by eliminating rival products going forward.
However, we believe that competition remains stiff for Oracle, which will limit its growth abilities going forward. Oracle's hardware business continues to decline, putting massive pressure on the software side to perform consistently in order drive to growth. In such a scenario, cut-throat competition and sluggish IT spending will hurt profitability going forward.
We remain Neutral on a long-term basis. Currently, Oracle has a Zacks #3 Rank (Hold).
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
SOURCE Zacks Investment Research, Inc.